01
Same-day alerts
Critical changes hit your inbox the day they publish, not the next monthly digest.
When DCC, CDTFA, the legislature, or the federal government moves, you know the same day — with the operator action translated, not just the press release linked.
When DCC, CDTFA, or the legislature moves, you know inside 24 hours — with the operator action translated, not just the press release linked.
Real alerts from this month. Severity color-coded. Always cited. Always translated for operators.
Final rule published in the Federal Register today reschedules state-licensed medicinal cannabis. 280E treatment shifts for medical lines; adult-use treatment unchanged. June 29 DEA hearing pending on broader scope.
CDTFA bulletin reaffirms the 15% gross-receipts excise rate locked through June 30, 2028. POS configuration check recommended; receipt-disclosure language unchanged.
DCC field staff begin verifying SB 540 brochure compliance at storefront and online points of sale. Both languages required. Citation matrix posted to inspector handbooks.
DCC issues clarifying guidance on AB 1894 informational-panel requirements for integrated vaporizers. Brand owners notified; new label artwork required at next print run.
Public hearing notice published. Comment window opens May 6. Operational impact for California licensees still indirect; we will brief if scope shifts.
Limited Partner Aggregation threshold drops to 10% effective May 15. Re-disclosure of financial-interest holders required from any licensee with ownership stack changes since 2024 renewal.
Department of Cannabis Regulation publishes new processing windows for Tier 1 and Tier 2 equity applicants. Pending applications routed to a refreshed queue.
Senate Appropriations adds clarifying language to the SB 1186 framework on local medical-delivery preemption. No operator action required at this time.
Federal rescheduling. AB 564 excise framework. SB 540 retailer brochure. AB 1894 vape labeling. SB 1186 medical-delivery preemption. The LPA threshold drop. Any one missed sweep is the citation in the next inspection notice.
Critical changes hit your inbox the day they publish, not the next monthly digest.
Pick your sources: DCC, CDTFA, state legislature, federal/DEA, your local jurisdiction.
Alerts scoped to your license types and SKUs — no noise from rules that do not touch you.
Each alert names what to change, who owns it, and the citation behind it. Not just news.
A compact view of the last seven days. No alert is published unless it changes something operators do.
Most regulatory news services link the agency’s announcement and call it a day. Compliance Alerts translates the announcement into the operator’s next action — with the named CCR/BPC anchor, the affected license types, and the deadline that started the moment the rule landed.
The DOJ’s administrative action under 21 USC §812 reschedules state-licensed medicinal cannabis to Schedule III. IRC §280E only applies to Schedule I/II controlled substances — medical operators no longer fall inside its scope. Adult-use remains Schedule I; the broader DEA rescheduling hearing is set for June 29, 2026.
A reporter’s framing. A trade publication’s analysis. Useful for context. Not citation-anchored. Not actionable on its own.
DCC’s announcement. CDTFA’s notice. Authoritative on what the agency wants you to know. Silent on what it means for your specific license type.
Named CCR/BPC anchor. Affected license types. Deadline. Operator action list. Routes into your Compliance Control Center as a scheduled task.
“When the rule changes, the meeting is already on your calendar.”